XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Equity - USD ($)
$ in Thousands
Common Stock [Member]
Series A
Common Stock [Member]
Class B
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Noncontrolling interests
Treasury Stock
Class B
Total
Balance at Jul. 31, 2023 $ 8 $ 236 $ 264,010 $ (167,333) $ 3,372 $ (3,664) $ 96,629
Balance (in Shares) at Jul. 31, 2023 787,163 23,490,527            
Balance (in Shares) at Jul. 31, 2023              
Consolidated net loss (34,410) (30,593) (65,003)
Stock-based compensation $ 3 2,293 2,296
Stock-based compensation (in Shares) 506,826            
Shares withheld for payroll taxes $ (1) (135) (136)
Shares withheld for payroll taxes (in Shares) (75,918)            
Sale of Rafael Medical Devices membership units 869 56 925
Noncontrolling interest in Day Three acquisition 1,151 1,151
Gain on RP Finance consolidation 7,600 7,600
Paid-in capital arising from Cornerstone Acquisition 7,260 7,260
Noncontrolling interest arising from Cornerstone Acquisition 27,501 27,501
Noncontrolling interest arising from RP Finance Consolidation 12,667 12,667
Elimination of RP Finance investment in Cornerstone (1,849) (3,082) (4,931)
Purchases of treasury stock $ (168) (168)
Purchases of treasury stock (in Shares) (101,487)            
Purchases of treasury stock (in Shares)             101,487  
Dissolution of Levco 19 37 56
Unrealized gain on available-for-sale securities 464 464
Foreign currency translation adjustment (53) (53)
Balance at Jul. 31, 2024 $ 8 $ 238 280,048 (201,743) 3,802 4,073 $ (168) $ 86,258
Balance (in Shares) at Jul. 31, 2024 787,163 23,819,948            
Balance (in Shares) at Jul. 31, 2024             101,487 101,487
Consolidated net loss (30,520) (123) $ (30,643)
Stock-based compensation $ 4 2,124 2,128
Stock-based compensation (in Shares) 473,514            
Forfeiture of restricted stock (5) (5)
Forfeiture of restricted stock (in Shares) (31,875)            
Shares withheld for payroll taxes (215) (215)
Shares withheld for payroll taxes (in Shares) (135,386)            
Sale of Rafael Medical Devices membership units 44 44
Shares issued in connection with Cyclo Merger $ 71 14,621 14,692
Shares issued in connection with Cyclo Merger (in Shares) 7,132,228            
Rollover options issued in connection with Cyclo Merger 360 360
Replacement Warrants issued in connection with Cyclo Merger 472 472
Issuance of common stock in Rights Offering, net of transaction costs $ 195 24,712 24,907
Issuance of common stock in Rights Offering, net of transaction costs (in Shares) 19,531,268            
DTLM shares issued in connection with the DTLM Sale Transactions 30 30
Unrealized gain on available-for-sale securities 247 247
Foreign currency translation adjustment 96 96
Balance at Jul. 31, 2025 $ 8 $ 508 $ 322,161 $ (232,263) $ 4,145 $ 3,980 $ (168) $ 98,371
Balance (in Shares) at Jul. 31, 2025 787,163 50,789,697            
Balance (in Shares) at Jul. 31, 2025             101,487 101,487